TOKYO -- Japan's Fujifilm will adopt next fiscal year new technology that uses artificial intelligence to increase its volume of biopharmaceutical drugs by nearly 40% without any additional equipment.
Artificial intelligence
Fujifilm to harness AI to ramp up biopharma output 40%
New tech to boost antibody production using current equipment
A staffer works at a Fujifilm contract biopharmaceuticals site in the U.K. The company is pouring billions of dollars into its biopharmaceuticals operations. (Photo by Fujifilm)
Read Next
Latest on Artificial intelligence
